SCHEMBL4499569

SCHEMBL4499569

CN(C(=O)CN1CCN(C(=O)OC(C)(C)C)CC1)c1ccc(N/C(=C2\C(=O)Nc3cc(Cl)ccc32)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
AAK1 Q2M2I8 1/20 0.38
ALDH1A1 P00352 4/20 0.37
MAPT P10636 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
GFER P55789 1/20 0.37
ANO1 Q5XXA6 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
TACR1 P25103 1/20 0.36
ESR2 Q92731 1/20 0.35
CNR1 P21554 1/20 0.35
UTS2R Q9UKP6 1/20 0.35
ABCB1 P08183 1/20 0.35
CRBN Q96SW2 1/20 0.35
MDM4 O15151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491928 0.93 MEN1 (0.39) MEN1KMT2AMAPTANO1UTS2R
SCHEMBL4495850 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL4504075 0.91 MEN1 (0.40) MEN1KMT2AAAK1ALDH1A1MAPT
SCHEMBL4490086 0.90 CETP (0.40) AAK1ALDH1A1MAPTCHRM2CHRM4
SCHEMBL4485411 0.89 AAK1 (0.46) DRD4AAK1ALDH1A1MAPTTDP1
SCHEMBL4485414 0.89 AAK1 (0.46) DRD4AAK1ALDH1A1MAPTTDP1
SCHEMBL4505574 0.89 DRD4 (0.44) DRD4AAK1ALDH1A1MAPTTDP1
SCHEMBL4505579 0.89 DRD4 (0.44) DRD4AAK1ALDH1A1MAPTTDP1
SCHEMBL4489310 0.89 DRD4 (0.43) DRD4MEN1KMT2AAAK1ALDH1A1
SCHEMBL4489305 0.89 DRD4 (0.43) DRD4MEN1KMT2AAAK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR DRD4 1051/4885MEN1 1288/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.